Is there a circadian variation in 5-Fluorouracil (5FU) plasma concentration (Cp) given by continuous infusion?

被引：0
|
作者：
Strocchi, E
Camaggi, CM
Martoni, A
Sereni, A
Pannuti, R
Pittureri, C
Cacciari, N
Zamagni, C
Pannuti, F
机构：
[1] ANT Lab, Dept Organ Chem, Bologna, Italy
[2] S Orsola M Malpighi Hosp, Div Med Oncol, Bologna, Italy
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
243P
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [1] LEVELS OF 5-FLUOROURACIL (5FU) IN PLASMA OF PATIENTS TREATED BY DRUG INFUSION
    HILLCOAT, BL
    MCCULLOCH, PB
    FIGUEREDO, A
    ROSENFELD, J
    KAWAI, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 199 - 199
  • [2] CONTINUOUS 5-FLUOROURACIL (5FU) INFUSION IN CARCINOMA OF THE PANCREAS - A PHASE-II STUDY
    HANSEN, R
    QUEBBEMAN, E
    RITCH, P
    CHITAMBAR, C
    ANDERSON, T
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1988, 295 (02): : 91 - 93
  • [3] GENOTOXIC ACTION OF 5-FLUOROURACIL (5FU)
    ZACCARO, L
    ROSSI, AM
    BATTOLLA, R
    MUTATION RESEARCH, 1987, 181 (02): : 320 - 320
  • [4] Fluctuation in Plasma 5-Fluorouracil Concentration During Continuous 5-Fluorouracil Infusion for Colorectal Cancer
    Matsumoto, Hideo
    Okumura, Hideo
    Murakami, Haruaki
    Kubota, Hisako
    Higashida, Masaharu
    Tsuruta, Atsushi
    Tohyama, Kaoru
    Hirai, Toshihiro
    ANTICANCER RESEARCH, 2015, 35 (11) : 6193 - 6199
  • [5] No circadian variation of dihydropyrimidine dehydrogenase, uridine phosphorylase, β-alanine, and 5-fluorouracil during continuous infusion of 5-fluorouracil
    Van Kuilenburg, ABP
    Poorter, RL
    Peters, GJ
    Van Gennip, AH
    Van Lenthe, H
    Stroomer, AEM
    Smid, K
    Noordhuis, P
    Bakker, PJM
    Veenhof, CHN
    PURINE AND PYRIMIDINE METABOLISM IN MAN IX, 1998, 431 : 811 - 816
  • [6] INTERACTION OF 5-FLUOROURACIL (5FU) WITH TUMOR ISCHEMIA
    EIBLEIBESFELDT, B
    STORZ, V
    KUMMERMEHR, J
    SCHALHORN, A
    BLUT, 1986, 53 (03): : 253 - 253
  • [7] INFLUENCE OF AGE ON PHARMACOKINETICS OF 5-FLUOROURACIL (5FU)
    SCHILCHER, RB
    DECKER, DA
    EVANS, LJ
    MARTINO, S
    KRESGE, C
    YOUNG, JD
    SAMAL, BA
    SINGHAKOWINTA, A
    BREAST CANCER RESEARCH AND TREATMENT, 1984, 4 (04) : 347 - 347
  • [8] INTERACTION OF MEROMELIA GENE AND 5-FLUOROURACIL (5FU)
    IGARASHI, E
    YASUDA, M
    TERATOLOGY, 1988, 38 (05) : 533 - 534
  • [9] THE INFLUENCE OF CIMETIDINE ON THE PHARMACOKINETICS OF 5-FLUOROURACIL (5FU)
    HARVEY, VJ
    SLEVIN, ML
    DILLOWAY, M
    CLARK, PI
    JOHNSTON, A
    LANT, AF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 362 - 362
  • [10] Continuous infusion 5-fluorouracil (5FU) as a novel treatment for heavily pretreated prostate cancer patients: An update.
    Manogue, Charlotte
    Cotogno, Patrick
    Moses, Marcus Marie
    Barata, Pedro C.
    Layton, Jodi Lyn
    Sartor, A. Oliver
    Lewis, Brian E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
12345